Respiratory Syncytial Virus Infection Management in Children

Primary Treatment Approach

The American Academy of Pediatrics recommends supportive care measures, including maintaining adequate hydration, fever control with antipyretics, and respiratory support as needed, as the mainstay of treatment for RSV infection in children 1
Oxygen therapy may be necessary for children with hypoxemia (oxygen saturation <90-92%) 1

The American Academy of Pediatrics states that palivizumab is not indicated for treatment of established RSV infection but is only approved for prevention in specific high-risk groups 1
For immunocompromised children with RSV infection, oral or aerosolized ribavirin may be considered in select cases to reduce progression to lower respiratory tract infection 1
Children with profound lymphopenia are at higher risk for progression to lower respiratory tract disease and should be monitored more closely 2, 1

Infants with severe respiratory distress, inability to maintain hydration, or oxygen saturation <90% despite supplemental oxygen require hospitalization 1
Children with underlying conditions such as prematurity, chronic lung disease, congenital heart disease, or immunocompromised status may need earlier hospitalization due to higher risk of severe disease 3, 1
Most RSV hospitalizations occur in children under 5 years of age, with 75% occurring in infants younger than 12 months 4

Antibiotics should not be routinely prescribed for RSV infection unless there is evidence of bacterial co-infection 1
Palivizumab has no therapeutic benefit in treating established RSV infection and should not be used for this purpose 4, 1

Strict infection control measures, including hand hygiene and proper handling of respiratory secretions, are essential to prevent RSV transmission 1

Several RSV vaccines are in development, with promising results in clinical trials for maternal immunization to protect infants 5, 6